Aqix Limited Logo AQIX® Fluid Technology.
Designed-Developed-Patented-Manufactured.
The World's Only Synthetic Human Interstitial Fluid


Latest news:

JUNE 2011

Aqix Limited is awarded a Research and Development Grant from the Technology Strategy Board for intravenous application of AQIX® RS-I.

AUGUST 2011

Aqix Limited patent for the intravenous application of AQIX® RS-I is granted in South Africa.

APRIL 2012

Aqix Limited is to participate as an SME member of the Consortium on Organ Preservation in Europe (COPE) grant award for €5.9M during 2013-17 to provide AQIX® RS-I as the base solution in the quest for improved, normothermic graft preservation of human donor organs.

DECEMBER 2012

Aqix Limited receives a notification of intent from the European Patent Office to be granted a EU patent filed in July, 2008, for applications of AQIX® RS-I involving blood/body fluid volume replacement therapies.

 

FEBRUARY 2013

European Patent Office grants Aqix Ltd a EU patent for intravenous applications of AQIX® RS-I involving blood/body fluid volume replacement therapies.



AQIX® RS-I 'ready-to-use' Kit



An immediately 'ready-to-use' transport and storage solution for the collection of a wide range of tissue biopsy samples. Samples can be placed directly into the solution without any further manipulation to either the biopsy sample or kit.

For more details on reconstitution see our Standard Procedure on Collection and Transportation.


Formulation


AQIX® RS-I 1x kit is provided as a sterile solution in 8 rigid, leak-proof, transparent containers each holding 125 mL of the carbogenated AQIX® RS-I 1x 'ready-to-use' solution.

Each AQIX® RS-I 1x kit is prepared to order by Aqix Limited.


Reconstitution


No further manipulation is required prior to use.


Shelflife


AQIX® RS-I 1x 'ready-to-use' solution has a shelf life of 6 months from the date of preparation if stored at 2-8°C.